Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina
Screening in selected but still wide populations such as women with recurrent fetal loss, placental insufficiency, pre-eclampsia, or needing oral contraception, or programmed high-risk surgery in both sexes, is still controversial. Knowledge of the prevalence of these polymorphisms in the general po...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | JOUR |
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00493848_v100_n3_p127_Genoud |
| Aporte de: |
| id |
todo:paper_00493848_v100_n3_p127_Genoud |
|---|---|
| record_format |
dspace |
| spelling |
todo:paper_00493848_v100_n3_p127_Genoud2023-10-03T14:52:36Z Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina Genoud, V. Castañon, M. Annichino-Bizzacchi, J. Korin, J. Kordich, L. Factor V Leiden MTHFR Prevalence Prothrombin 20210 Thrombophilia 5,10 methylenetetrahydrofolate reductase (FADH2) blood clotting factor 5 Leiden DNA fragment homocysteine oral contraceptive agent phospholipid antibody protein C protein S prothrombin activated protein C resistance adult aged Argentina article blood donor controlled study deep vein thrombosis DNA polymorphism gene mutation genetic disorder genetic variability heterozygosity homozygosity human human tissue lung embolism prevalence priority journal risk factor thromboembolism thrombophilia Adult Aged Brazil Factor V Genetic Screening Heterozygote Homozygote Humans Methylenetetrahydrofolate Reductase (NADPH2) Middle Aged Oxidoreductases Acting on CH-NH Group Donors Point Mutation Polymorphism, Genetic Prevalence Prothrombin Risk Factors Thrombophilia Screening in selected but still wide populations such as women with recurrent fetal loss, placental insufficiency, pre-eclampsia, or needing oral contraception, or programmed high-risk surgery in both sexes, is still controversial. Knowledge of the prevalence of these polymorphisms in the general population is useful in order to take desicions that could considerably increase the burden to health resources, even in developed countries. Fil:Castañon, M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Kordich, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00493848_v100_n3_p127_Genoud |
| institution |
Universidad de Buenos Aires |
| institution_str |
I-28 |
| repository_str |
R-134 |
| collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
| topic |
Factor V Leiden MTHFR Prevalence Prothrombin 20210 Thrombophilia 5,10 methylenetetrahydrofolate reductase (FADH2) blood clotting factor 5 Leiden DNA fragment homocysteine oral contraceptive agent phospholipid antibody protein C protein S prothrombin activated protein C resistance adult aged Argentina article blood donor controlled study deep vein thrombosis DNA polymorphism gene mutation genetic disorder genetic variability heterozygosity homozygosity human human tissue lung embolism prevalence priority journal risk factor thromboembolism thrombophilia Adult Aged Brazil Factor V Genetic Screening Heterozygote Homozygote Humans Methylenetetrahydrofolate Reductase (NADPH2) Middle Aged Oxidoreductases Acting on CH-NH Group Donors Point Mutation Polymorphism, Genetic Prevalence Prothrombin Risk Factors Thrombophilia |
| spellingShingle |
Factor V Leiden MTHFR Prevalence Prothrombin 20210 Thrombophilia 5,10 methylenetetrahydrofolate reductase (FADH2) blood clotting factor 5 Leiden DNA fragment homocysteine oral contraceptive agent phospholipid antibody protein C protein S prothrombin activated protein C resistance adult aged Argentina article blood donor controlled study deep vein thrombosis DNA polymorphism gene mutation genetic disorder genetic variability heterozygosity homozygosity human human tissue lung embolism prevalence priority journal risk factor thromboembolism thrombophilia Adult Aged Brazil Factor V Genetic Screening Heterozygote Homozygote Humans Methylenetetrahydrofolate Reductase (NADPH2) Middle Aged Oxidoreductases Acting on CH-NH Group Donors Point Mutation Polymorphism, Genetic Prevalence Prothrombin Risk Factors Thrombophilia Genoud, V. Castañon, M. Annichino-Bizzacchi, J. Korin, J. Kordich, L. Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| topic_facet |
Factor V Leiden MTHFR Prevalence Prothrombin 20210 Thrombophilia 5,10 methylenetetrahydrofolate reductase (FADH2) blood clotting factor 5 Leiden DNA fragment homocysteine oral contraceptive agent phospholipid antibody protein C protein S prothrombin activated protein C resistance adult aged Argentina article blood donor controlled study deep vein thrombosis DNA polymorphism gene mutation genetic disorder genetic variability heterozygosity homozygosity human human tissue lung embolism prevalence priority journal risk factor thromboembolism thrombophilia Adult Aged Brazil Factor V Genetic Screening Heterozygote Homozygote Humans Methylenetetrahydrofolate Reductase (NADPH2) Middle Aged Oxidoreductases Acting on CH-NH Group Donors Point Mutation Polymorphism, Genetic Prevalence Prothrombin Risk Factors Thrombophilia |
| description |
Screening in selected but still wide populations such as women with recurrent fetal loss, placental insufficiency, pre-eclampsia, or needing oral contraception, or programmed high-risk surgery in both sexes, is still controversial. Knowledge of the prevalence of these polymorphisms in the general population is useful in order to take desicions that could considerably increase the burden to health resources, even in developed countries. |
| format |
JOUR |
| author |
Genoud, V. Castañon, M. Annichino-Bizzacchi, J. Korin, J. Kordich, L. |
| author_facet |
Genoud, V. Castañon, M. Annichino-Bizzacchi, J. Korin, J. Kordich, L. |
| author_sort |
Genoud, V. |
| title |
Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| title_short |
Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| title_full |
Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| title_fullStr |
Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| title_full_unstemmed |
Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina |
| title_sort |
prevalence of three prothrombotic polymorphisms: factor v g1691a, factor ii g20210a and methylenetetrahydrofolate reductase (mthfr) c 677t in argentina |
| url |
http://hdl.handle.net/20.500.12110/paper_00493848_v100_n3_p127_Genoud |
| work_keys_str_mv |
AT genoudv prevalenceofthreeprothromboticpolymorphismsfactorvg1691afactoriig20210aandmethylenetetrahydrofolatereductasemthfrc677tinargentina AT castanonm prevalenceofthreeprothromboticpolymorphismsfactorvg1691afactoriig20210aandmethylenetetrahydrofolatereductasemthfrc677tinargentina AT annichinobizzacchij prevalenceofthreeprothromboticpolymorphismsfactorvg1691afactoriig20210aandmethylenetetrahydrofolatereductasemthfrc677tinargentina AT korinj prevalenceofthreeprothromboticpolymorphismsfactorvg1691afactoriig20210aandmethylenetetrahydrofolatereductasemthfrc677tinargentina AT kordichl prevalenceofthreeprothromboticpolymorphismsfactorvg1691afactoriig20210aandmethylenetetrahydrofolatereductasemthfrc677tinargentina |
| _version_ |
1782024776003354624 |